BioNexus Gene Lab Corp (NASDAQ: BGLC)
$0.3000
+0.0081 ( +3.45% ) N/A
BioNexus Gene Lab Corp through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of 11 different diseases.
Market Data
Open
$0.3000
Previous close
$0.2919
Volume
N/A
Market cap
$5.24M
Day range
$0.2900 - $0.2900
52 week range
$0.2810 - $3.3900
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
10-q | Quarterly Reports | 68 | May 15, 2024 |
8-k | 8K-related | 15 | May 09, 2024 |
8-k | 8K-related | 17 | Apr 18, 2024 |
10-k | Annual reports | 84 | Apr 16, 2024 |
8-k | 8K-related | 15 | Apr 01, 2024 |
nt | Quarterly Reports | 1 | Mar 28, 2024 |
10-q/a | Quarterly Reports | 65 | Mar 26, 2024 |
def | Proxies and info statements | 1 | Feb 29, 2024 |
pre | Proxies and info statements | 1 | Jan 26, 2024 |
10-q | Quarterly Reports | 5 | Nov 20, 2023 |